Joyce Despe
Gerontology · Maywood, ILNPI 1851864839
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $716 of the $815 with a category attached, or 87.9%. 10 manufacturers reported payments, led by Daiichi Sankyo Inc. at 27.5% of the total.
Across 15 payments — averaging $54.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$224
- Deciphera Pharmaceuticals Inc.$131
- Merck$125
- Mirati Therapeutics, Inc.$119
- Lilly USA, LLC$83
- Johnson & Johnson$31
- plus $102 from 4 others
What the payments were for
- Food & beverage$71688%
- Education$9912%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $224 |
| Deciphera Pharmaceuticals Inc. | 1 | $131 |
| Merck | 3 | $125 |
| Mirati Therapeutics, Inc. | 1 | $119 |
| Lilly USA, LLC | 3 | $83 |
| Johnson & Johnson | 1 | $31 |
| Genentech USA, Inc. | 1 | $30 |
| Gilead | 1 | $29 |
| Jazz Pharmaceuticals Inc. | 1 | $28 |
| Amgen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$815 in reported general payments places this provider in the 75th percentile of 180 gerontology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 90 | $10,402 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 126 | $4,071 |
| Oxycodone Hcl | 62 | $3,018 |
| Morphine Sulfate | 32 | $1,705 |
| Gabapentin | 73 | $786 |
| Ondansetron OdtOndansetron | 16 | $648 |
| Mirtazapine | 27 | $424 |
| Prochlorperazine Maleate | 18 | $365 |
| Morphine Sulfate ErMorphine Sulfate | 16 | $331 |
| Hydromorphone Hcl | 14 | $303 |
| Pregabalin | 24 | $279 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $240 |
| Methadone Hcl | 14 | $186 |
| Duloxetine Hcl | 14 | $137 |
| Ibuprofen | 12 | $137 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Maywood
- Elyse FairandMaywood$1K
- Joseph StokesChicago$16K
- Stephanie VerderameRockford$15K
- Megan BonisNiles$15K
- Cheryl RogersKankakee$15K
- June LosurdoHinsdale$9K
- Hayley MillsMoline$7K
- Carlyn NewellOlympia Fields$7K
- Ann WaldronMatteson$6K
- Kristin RyanArlington Heights$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.